|
Study | Population (E/C) | Age (mean or range) | Diagnostic criteria | Outcome measurements | Adverse events |
|
Baiyin 2014 [20] | 43/44 | E: 27–56; C: 28–54 | ARA 1977 | Clinical effect, uric acid | NR |
Chenle 2015 [21] | 25/25 | E: 25–58; C: 23–60 | ARA 1977 | Clinical effect | NR |
Gong and Chen 2014 [22] | 60/60 | NR | ARA 1977 | Clinical effect | NR |
Gui and Chen 2014 [23] | 32/28 | E: 28–65; C: 26–62 | SATCM 1994 | Clinical effect | Yes |
He et al. 2008 [24] | 30/30 | E: 28–67; C: 30–65 | SATCM 1994 | Clinical effect | Yes |
Hu et al. 2010 [25] | 68/60 | E: 45.42 ± 11.46; C: 46.74 ± 11.22 | ARA 1977 | Clinical effect, uric acid, CRP, ESR | Yes |
Jin et al. 2012 [26] | 30/30 | E: 23-67; C: 25–66 | ARA 1977 | Clinical effect, uric acid | Yes |
Li et al. 2013 [27] | 31/29 | E: 49.67 ± 19.3; C: 46.52 ± 10.29 | ARA 1977 | Clinical effect, uric acid | Yes |
Liu et al. 2008 [28] | 56/44 | E: 34–70: C: 33–74 | SATCM 1994 | Clinical effect, uric acid | NR |
Liu et al. 2014 [29] | 44/41 | E: 20–50; C: 18–52 | ARA 1977 | Clinical effect, uric acid, VAS score | Yes |
Liu 2014 [30] | 87/87 | E: 44.1; C: 43.4 | ARA 1977 | Clinical effect, uric acid, CRP, ESR | Yes |
Ma 2002 [31] | 48/30 | E: 31–78; C: 29–72 | ARA 1977 | Clinical effect, uric acid | NR |
Ma 2004 [32] | 42/30 | E: 31–78; C: 29–72 | ARA 1977 | Clinical effect, uric acid | NR |
Wang 2013 [33] | 40/20 | E: 23–70; C: 23–70 | ARA 1977 | Clinical effect, ESR, CRP, uric acid | Yes |
Wu et al. 2012 [34] | 34/32 | E: 32–60; C: 33–63 | SATCM 1994 | Clinical effect, uric acid, CRP, ESR, VAS score | NR |
Xi et al. 2006 [35] | 66/64 | E: 50.1 ± 5.2; C: 45.1 ± 6.1 | ARA 1977 | Clinical effect, uric acid, VAS score | NR |
Xie et al. 2007 [36] | 30/30/30 | E: 40–70; C1: 42–69; C2: 43–71 | ARA 1977 | Clinical effect, uric acid | NR |
Xie et al. 2009 [37] | 30/30 | E: 32–65; C: 40–67 | SATCM 1994 | Clinical effect, uric acid | Yes |
Yan 2009 [38] | 40/20 | E: 35–75; C: 38–76 | ARA 1977 | Clinical effect, uric acid | Yes |
Yin et al. 2005 [39] | 40/30/30 | E1: 36–72: E2: 31–69: C: 34–76 | SATCM 1994 | Clinical effect, uric acid | NR |
Zhang 2010 [40] | 28/29 | E: 38–79; C: 29–80 | SATCM 1994 | Clinical effect | NR |
Zhao 2007 [41] | 30/30 | E: 31–68; C: 30–70 | SATCM 1994 | Clinical effect, uric acid, VAS score | NR |
Zhao et al. 2009 [42] | 30/30 | E: 33–70; C: 32–71 | ARA 1977 | Clinical effect, uric acid | NR |
Zhou et al. 2012 [43] | 80/80 | E: 36–65; C: 37–64 | SATCM 1994 | Clinical effect, uric acid, VAS score, ESR | NR |
Zhou 2014 [44] | 20/20 | E: 18–48; C: 17–50 | SATCM 1994 | Clinical effect | NR |
Zong et al. 2011 [45] | 20/20 | E: 34–72; C: 30–70 | ARA 1977 | Clinical effect, uric acid | NR |
Zou et al. 2006 [46] | 30/30/30 | E1: 32–70; E2: 31–72; C: 35–71 | SATCM 1994 | Clinical effect, uric acid, VAS score | NR |
Zou et al. 2007 [47] | 30/30 | E: 32–70; C: 31–72 | SATCM 1994 | Clinical effect, uric acid, VAS score | NR |
|